journal article·2023Open access

Production of Polycaprolactone/Atorvastatin Films for Drug Delivery Application

Debora Baptista Pereira, Beatriz Ferreira de Carvalho Patricio, Talita Goulart da Silva, Hellen Regina Oliveira de Almeida, Marcelo Henrique da Cunha Chaves, Michelle Alvares Sarcinelli, Helvécio Vinícius Antunes Rocha, Tiago dos Santos Mendonça, Tiago José Bandeira Sales, Roberta Helena Mendonça

Materials Research· Volume 26· Issue suppl 1

Abstract

Developing biomaterials for tissue regeneration is a promising alternative for the recovery of various tissues, including bone. Atorvastatin (ATV) has a series of beneficial effects which includes bone anabolism, vasodilating, and anti-inflammatory actions. The main objective of this work was to produce and characterize polycaprolactone (PCL) matrices incorporated with ATV. Samples were prepared by the solvent casting technique. Scanning electron microscopy (SEM), X-Ray diffraction (XRD), Fourier transform infrared spectrometry (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and in vitro release studies were performed. FTIR analysis showed that no chemical bonds were formed between PCL and ATV. SEM analysis showed that the amount of ATV affects sample morphology. According to XRD and thermal analysis, the main ATV characteristics were maintained. The studies showed that PCL/ATV samples release the drug in a prolonged way since its release reaches around 50% after 15000 minutes of analysis and the model that showed the best fit for the studied matrices was the Higuchi model, with a correlation coefficient above 0.95.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Drug Solubulity and Delivery Systems · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Universidade Federal Rural do Rio de Janeiro, Brasil

Instituto de Tecnologia Farmacêutica, Brasil; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brasil; Universidade Federal do Estado do Rio de Janeiro, Brasil

Instituto de Tecnologia Farmacêutica, Brasil; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brasil

Universidade Estadual do Rio de Janeiro, Brasil

Universidade Federal Rural do Rio de Janeiro, Brasil; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Brasil

References (41)

Show source-provided references
1. Biomateriais com aplicação na regeneração óssea - método de análise e perspectivas futuras
2. Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples10.1208/s12249-010-9419-7 ↗
3. Micronization of atorvastatin calcium by antisolvent precipitation process10.1016/j.ijpharm.2009.02.015 ↗
4. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial10.1210/jc.2006-1909 ↗
5. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells10.1530/JOE-10-0411 ↗
6. Statin use, bone mineral density, and fracture risk10.1001/archinte.162.5.537 ↗
7. Local delivery of controlled-release simvastatin/PLGA /HA p microspheres enhances bone repair
8. Efficacy of local and systemic statin delivery on the osseointegration of implants: a systematic review10.11607/jomi.4955 ↗
9. The return of a forgotten polymer - polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
10. Production of 3D scaffolds applied to tissue engineering using chitosan swelling as a porogenic agent10.1002/app.38735 ↗
11. Recent developments in novel drug delivery systems for wound healing10.1517/17425247.2015.1070143 ↗
12. Alendronate PLGA microspheres with high loading efficiency for dental applications10.1080/02652040701439807 ↗
13. Enhancement of alendronate encapsulation in chitosan nanoparticles10.1016/j.jddst.2015.04.007 ↗
14. Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate10.1016/j.ijpharm.2015.03.003 ↗
15. PCL films incorporated with paclitaxel/5-fluorouracil: effects of formulation and spacial architecture on drug release10.1016/j.ijpharm.2012.02.007 ↗
16. Antibacterial electrospun polycaprolactone nanofibers reinforced by halloysite nanotubes for tissue engineering10.3390/polym14040746 ↗
17. Electrospinning over solvent casting: tuning of mechanical properties of membranes10.1038/s41598-018-23378-3 ↗
18. Anisotropic fibrous scaffolds for articular cartilage regeneration10.1089/ten.tea.2011.0606 ↗
19. Comparison of cellular proliferation on dense and porous PCL scaffolds
20. Surface properties and biocompatibility of solvent-cast poly[ε-caprolactone] films10.1016/j.biomaterials.2003.12.003 ↗
21. Poly-ϵ-caprolactone microspheres and nanospheres: an overview10.1016/j.ijpharm.2004.01.044 ↗
22. PCL/Ibuprofen implants fabricated by selective laser sintering for orbital repair10.1016/j.procir.2015.11.013 ↗
23. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering10.1016/j.biomaterials.2004.11.057 ↗
24. Advanced biomaterials for skeletal tissue regeneration: instructive and smart functions10.1016/j.mser.2007.12.001 ↗
25. Cholesterol and cartilage do not mix well10.1038/s41584-019-0204-z ↗
26. The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis10.1038/s41586-019-0920-1 ↗
27. Bruschi ML · 2015
28. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
29. Polycaprolactone- and polycaprolactone/ceramic-based 3D-bioplotted porous scaffolds for bone regeneration: a comparative study10.1016/j.msec.2017.05.003 ↗
30. Compatibility study between atorvastatin and excipients using DSC and FTIR10.1007/s10973-015-5077-z ↗
31. Solubility considerations in relative block crystallization and morphology of PEO‐b‐PCL films
32. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability10.1016/j.apsb.2012.05.002 ↗
33. Nanocomposites of PLA and PCL based on montmorillonite and sepiolite10.1016/j.msec.2008.11.005 ↗
34. Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions10.1016/j.powtec.2015.08.047 ↗
35. Sonje VM · 2010 · 35 · 110.1016/S1871-5125(10)35001-1 ↗
36. Morphological changes of annealed poly-ε-caprolactone by enzymatic degradation with lipase10.1002/polb.21889 ↗
37. Controlled drug delivery systems: current status and future directions10.3390/molecules26195905 ↗
38. Ren J · 2010 · 240
39. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7 ↗
40. 3D printing of HA / PCL composite tissue engineering scaffolds10.1016/j.aiepr.2019.09.003 ↗
41. 3D printed PCL/SrHA scaffold for enhanced bone regeneration10.1016/j.cej.2019.01.015 ↗